HCSGD entry for NT5E


1. General information

Official gene symbolNT5E
Entrez ID4907
Gene full name5'-nucleotidase, ecto (CD73)
Other gene symbolsCD73 E5NT NT NT5 NTE eN eNT
Links to Entrez GeneLinks to Entrez Gene

2. Neighbors in the network

color bar

3. Gene ontology annotation

GO ID

GO term

Evidence

Category

GO:0000166Nucleotide bindingIEAmolecular_function
GO:0005737CytoplasmIDAcellular_component
GO:0005886Plasma membraneIDA TAScellular_component
GO:0006144Purine nucleobase metabolic processTASbiological_process
GO:0006195Purine nucleotide catabolic processTASbiological_process
GO:0006196AMP catabolic processIEAbiological_process
GO:0006206Pyrimidine nucleobase metabolic processTASbiological_process
GO:0006259DNA metabolic processTASbiological_process
GO:00082535'-nucleotidase activityEXPmolecular_function
GO:0009166Nucleotide catabolic processIEAbiological_process
GO:0016020MembraneTAScellular_component
GO:0016311DephosphorylationEXP TASbiological_process
GO:0016787Hydrolase activityIEAmolecular_function
GO:0016788Hydrolase activity, acting on ester bondsIEAmolecular_function
GO:0031225Anchored component of membraneIEAcellular_component
GO:0044281Small molecule metabolic processTASbiological_process
GO:0046086Adenosine biosynthetic processIEAbiological_process
GO:0046135Pyrimidine nucleoside catabolic processTASbiological_process
GO:0046872Metal ion bindingIEAmolecular_function
GO:0050728Negative regulation of inflammatory responseIEAbiological_process
GO:0055086Nucleobase-containing small molecule metabolic processTASbiological_process
GO:0070062Extracellular vesicular exosomeIDAcellular_component
Entries Per Page
Displaying Page of

4. Expression levels in datasets

  • Meta-analysis result

p-value upp-value downFDR upFDR down
0.00255931390.98889607920.13782591841.0000000000

  • Individual experiment result
    ( "-" represent NA in the specific microarray platform )

Data sourceUp or downLog fold change
GSE11954Up1.1993118706
GSE13712_SHEARUp1.1598929594
GSE13712_STATICUp0.4889210090
GSE19018Up0.3577211838
GSE19899_A1Up0.4699158327
GSE19899_A2Up0.4614618342
PubMed_21979375_A1Up0.2174952448
PubMed_21979375_A2Down-0.0155216842
GSE35957Down-0.1709058807
GSE36640Up0.8586933832
GSE54402Up0.4587164968
GSE9593Up0.7816365794
GSE43922Up0.2463110686
GSE24585Up0.9976117454
GSE37065Up0.3912278465
GSE28863_A1Up0.0524855111
GSE28863_A2Up0.4719248167
GSE28863_A3Down-0.3396158049
GSE28863_A4Down-0.0715662690
GSE48662Down-0.2941777690

5. Regulation relationships with compounds/drugs/microRNAs

  • Compounds

Not regulated by compounds

  • Drugs

Name

Drug

Accession number

PentoxifyllineDB00806 APRD00121

  • MicroRNAs

  • mirTarBase

MiRNA_name

mirBase ID

miRTarBase ID

Experiment

Support type

References (Pubmed ID)

hsa-miR-155-5pMIMAT0000646MIRT001529pSILAC//Proteomics;OtherFunctional MTI (Weak)18668040
hsa-miR-30a-5pMIMAT0000087MIRT005130pSILAC//Proteomics;OtherFunctional MTI (Weak)18668040
hsa-miR-124-3pMIMAT0000422MIRT022996Proteomics;MicroarrayFunctional MTI (Weak)18668037
hsa-miR-1MIMAT0000416MIRT023955ProteomicsFunctional MTI (Weak)18668040
hsa-miR-34a-5pMIMAT0000255MIRT025509ProteomicsFunctional MTI (Weak)21566225
Entries Per Page
Displaying Page of
  • mirRecord
No target information from mirRecord

6. Text-mining results about the gene

Gene occurances in abstracts of cellular senescence-associated articles: 15 abstracts the gene occurs.


PubMed ID of the article

Sentenece the gene occurs

26196672All cells were negative for leukocyte markers (CD19, CD34, CD45) and CD73 positive
25437179When compared with N-UC-MSCs, GDM-UC-MSCs showed decreased cell growth and earlier cellular senescence with accumulation of p16 and p53, even though they expressed similar levels of CD105, CD90, and CD73 MSC marker proteins
241703705 cc of bone marrow was needed to predictably isolate aBMSCs, and, regardless of methodology for harvest, cell-surface marker expression of CD73, CD90, CD105, and Stro-1 was similar for aBMSCs, being 89
23804221CONCLUSION: Our findings indicate that the combination of CD73 and CD39 allows the prospective purification from culture-expanded heterogeneous synovial MSC populations of a distinct MSC subset with greater chondro-osteogenic potency
22242193Long term treatment did not induce lineage commitment in terms of osteogenic pathways but maintained their clonogenic capacity, their surface marker characteristics (expression of CD73, CD90, CD105) and their multipotency to develop towards the chondrogenic, adipogenic and osteogenic pathways
21627568The surface expression of CD90 and CD73 was assessed by flow cytometry
20225285The expressions of CD166, CD49a, and CD106 decreased, whereas those of CD10, CD29, CD44, CD73, CD90, and CD105 showed no significant change
18056041b protein ratio, the stability of a number of glycolytic enzymes, and the instability of pyrimidine 5'-nucleotidase activity
2154283Increased 5'-nucleotidase activity induced by dibutyryl cyclic AMP treatment of cultured glial cells
2154283In an attempt to clarify the relationship between ecto-5'-nucleotidase (5'-N) activity and cell differentiation of glial cells, dibutyryl cyclic AMP (dBcAMP), which induces cell differentiation, was administrated to cultured rat glioma cells in logarithmic and confluent phases of cultivation
2559327Enhancement of 5'-nucleotidase activity of human leukemic cells after fractionation: implications for cancer and aging
2559327Previous studies reported that 5'-nucleotidase activity was undetectable or at much lower levels in the homogenate of human chronic lymphocytic leukemic (CCL) cells than in normal lymphocytes
2559327In the present study, 5'-nucleotidase specific activity in acute myelocytic leukemia (AML), which varied in a range from undetectable to 1
2559327In a further fractionation of the cytosol of various leukemic cells with ammonium sulfate, 5'-nucleotidase specific activity increased up to 14-fold in the 60% (NH4)2SO4 fraction, with a recovery of 1266 +/- 115%
2559327These data suggest that 5'-nucleotidase activity in fractionated leukemic cells is higher than reported previously and that the sum of 5'-nucleotidase activity in subcellular compartments is higher than that detected in the homogenate
2559327Furthermore, even when 5'-nucleotidase was undetectable in a homogenate, it became detectable in the plasma membranes, suggesting that its ecto-enzyme function is still active in leukemic cells
2559327The undetectable or low 5'-nucleotidase in the homogenate is indicative of (1) the enzyme itself being in an inactive form but becoming active after the fractionations, or (2) the presence of a factor(s) that prevents the enzyme from being detected but that is separated from the enzyme by the fractionations
2559327In both cases, the rate of nucleotide catabolism by inactive 5'-nucleotidase in rapidly proliferating leukemic cells should be slower than when the enzyme is active
2559327The present finding is consistent with our previous findings that during normal cell aging the high 5'-nucleotidase activity is associated with senescent non-proliferating cells but low or undetectable activity with rapidly proliferating immortal cells
2559327The implications of 5'-nucleotidase for DNA synthesis in aging and cancer are discussed
3021233Membrane-bound 5'-nucleotidase inhibitor in Ehrlich ascites tumour cells and newborn mouse liver
3021233The cell homogenate, when mixed with adult mouse liver homogenate, inhibited the 5'-nucleotidase activity of the latter, without affecting its p-nitrophenyl phosphate-hydrolysing activity
3021233From these results we conclude that a small molecular weight protein inhibitor(s) of 5'-nucleotidase is present in the plasma membrane of Ehrlich ascites tumour cells
2998326Implications of 5'-nucleotidase and its inhibitor for cellular aging and cancer
6307389Implications of a 5'-nucleotidase inhibitor in human leukemic cells for cellular aging and cancer
6307389Preincubating the mixed samples for 1, 20 and 45 min, respectively, before adding the substrate, the heated soluble fraction of RPMI 8402 cells did not increase the percentage of inhibition for 5'-nucleotidase of the homogenate of IMR-90 cells
6307389The present study suggest that the previously reported undetectability of 5'-nucleotidase in permanent cell lines could be due to the presence of a protein inhibitor for 5'-nucleotidase in these human leukemic cell lines
6307389It also supports the hypothesis that the increased 5'-nucleotidase activity in normal senescent cells in vitro may be a control in cellular aging that is missing from leukemic cells in vitro
449279In IMR-90 and CEF cells, both of which have a limited lifespan in vitro, 5'-nucleotidase activity increased 6- and 20-fold, respectively, with increasing population doublings
449279Of the six cell lines tested, the conspicuous enhancement in 5'-nucleotidase activity with increasing population doublings was observed only in normal cell lines and was absent in transformed cell lines
719132Absence of any detectable activity of the membrane marker enzyme 5'-nucleotidase in human red blood cells
719132We have investigated in human red blood cell membranes the presence of a 5'-nucleotidase, which is considered a general marker of plasma membranes
719132Thus, the ubiquitousness of 5'-nucleotidase in plasma membranes is questioned
Entries Per Page
Displaying Page of